Microalbuminuria: an important diagnostic tool.
The concept of microalbuminuria is reviewed. Measuring the urinary albumin excretion rate and testing for microalbuminuria is well established in the control and treatment of patients with insulin-dependent diabetes mellitus. Microalbuminuria predicts nephropathy and early cardiovascular death. In the presence of microalbuminuria frequent examinations are warranted for early detection of retinopathy, blood-pressure rise, and for optimizing the glycemic control. In patients with non-insulin-dependent diabetes, the independent value of microalbuminuria as a cardiovascular risk factor is not yet clarified. The urinary albumin excretion rate should be measured at diagnosis, because the indications are that presence of microalbuminuria reinforces the urge to intervene against other well-documented cardiovascular risk factors (hypertension, dyslipidemia, tobacco, and obesity). In the nondiabetic population, there is accumulating evidence that an elevated urinary albumin excretion rate is associated with early cardiovascular morbidity and mortality. Large scale cross-sectional and prospective studies are needed in order to clarify further the role of microalbuminuria as an independent risk factor in the background population.
Feldt-Rasmussen
B
B
Rigshospitalet University Hospital, Medical Department P, Copenhagen, Denmark.
Borch-Johnsen
K
K
Deckert
T
T
Jensen
G
G
Jensen
J S
JS
D000419:Albuminuria / Q000209:etiology* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000150:complications / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D011237:Predictive Value of Tests; D012307:Risk Factors